Kathleen Burns
Nurse Practitioner · Duarte, CANPI 1750794202
Payments from drug & device makers
Across 399 payments — averaging $411.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$44K
- Pfizer$43K
- Exelixis Inc.$29K
- Astellas Pharma US Inc$13K
- Sanofi$9K
- EMD Serono, Inc.$9K
- plus $16K from 29 others
Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 33 | $43,848 |
| Pfizer | 90 | $43,236 |
| Exelixis Inc. | 82 | $29,266 |
| Astellas Pharma US Inc | 37 | $13,270 |
| Sanofi | 19 | $9,490 |
| EMD Serono, Inc. | 16 | $9,200 |
| AVEO Pharmaceuticals, Inc. | 9 | $4,255 |
| Merck | 19 | $3,399 |
| AstraZeneca(2 entities) | 13 | $2,405 |
| Eisai Inc. | 10 | $1,997 |
| Janssen Scientific Affairs, LLC | 2 | $1,125 |
| Progenics Pharmaceuticals, Inc. | 5 | $312 |
| Johnson & Johnson | 10 | $301 |
| Dendreon Pharmaceuticals LLC | 4 | $274 |
| Sun Pharmaceutical Industries Inc. | 3 | $272 |
| Seagen Inc. | 5 | $264 |
| Bayer | 6 | $196 |
| Regeneron Healthcare Solutions, Inc. | 2 | $169 |
| AbbVie | 4 | $134 |
| Novartis | 5 | $121 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Genentech USA, Inc. | 3 | $71 |
| Teleflex LLC | 3 | $69 |
| Gilead | 2 | $63 |
| Tempus AI, Inc | 2 | $51 |
| Bristol Myers Squibb | 2 | $49 |
| Amgen | 3 | $46 |
| Mirati Therapeutics, Inc. | 1 | $45 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Pharmaessentia USA Corporation | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Myovant Sciences Inc. | 1 | $18 |
| Incyte Corporation | 1 | $17 |
How this compares
$164,194 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Duarte
- Erin KoppDuarte$107K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.